Efficacy and safety of Ergoferon versus oseltamivir in adult outpatients with seasonal influenza virus infection: a multicenter, open-label, randomized trial. [electronic resource]
- International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases Oct 2016
- 47-55 p. digital
Adolescent Adult Aged Antibodies--therapeutic use Antiviral Agents--therapeutic use CD4 Antigens--immunology Female Fever--drug therapy Histamine--immunology Humans Influenza, Human--drug therapy Interferon-gamma--immunology Male Middle Aged Oseltamivir--therapeutic use Outpatients Quality of Life Time Factors Treatment Outcome Young Adult